Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
Oskar Bergengren, Kelly Pekala, Konstantina Matsoukas, et al.
European Urology (2023) Vol. 84, Iss. 2, pp. 191-206
Open Access | Times Cited: 327

Showing 1-25 of 327 citing articles:

[161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617
Andrea Schaefer-Schuler, Caroline Burgard, Arne Blickle, et al.
Theranostics (2024) Vol. 14, Iss. 5, pp. 1829-1840
Open Access | Times Cited: 16
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
Yixiang Gu, Ruifeng Yang, Yang Zhang, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Long-term exposure to ambient air pollutants and risk of prostate cancer: a prospective cohort study
Yu Chen, Siru Yang, Jiahao Lin, et al.
Environmental Research (2025), pp. 121020-121020
Closed Access | Times Cited: 2
Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer
Vladimir Rogovskii, Vladimir V. Murugin, Nikolay Vorobyev, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Impact of UV-Irradiated Mesoporous Titania Nanoparticles (mTiNPs) on Key Onco- and Tumor Suppressor microRNAs of PC3 Prostate Cancer Cells
Andrea Méndez-García, Luis Alberto Bravo-Vázquez, Padmavati Sahare, et al.
Genes (2025) Vol. 16, Iss. 2, pp. 148-148
Open Access | Times Cited: 1
Causal relationship between immune cells and prostate cancer: a Mendelian randomization study
Zhipeng Ye, Xinpei Deng, Jinhui Zhang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 14
FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer
Na Liu, Anran Wang, Mengen Xue, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Association between circulating immune cells and the risk of prostate cancer: a Mendelian randomization study
Xuexue Hao, Congzhe Ren, Hang Zhou, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 11
Shared decision-making before prostate cancer screening decisions
Kelly Pekala, Daniela K. Shill, Mia Austria, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 6, pp. 329-338
Closed Access | Times Cited: 10
PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape
Ashaar Al-Akhras, Chadi Hage Chehade, Arshit Narang, et al.
Life (2024) Vol. 14, Iss. 2, pp. 198-198
Open Access | Times Cited: 10
Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study
Salvatore Vaccarella, Mengmeng Li, Freddie Bray, et al.
BMJ (2024), pp. e077738-e077738
Closed Access | Times Cited: 9
Vitamin D and potential effects on cancers: a review
Pouria Sobhi, Mohammad Bahrami, Faraz Mahdizadeh, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 8
Equol: a metabolite of gut microbiota with potential antitumor effects
Jing Lv, Shengkai Jin, Yuwei Zhang, et al.
Gut Pathogens (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 8
A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low- to Intermediate-Risk Prostate Cancer: A Tool to Improve Risk Stratification for Active Surveillance?
Jianliang Liu, Jordan Santucci, Dixon Woon, et al.
Life (2024) Vol. 14, Iss. 1, pp. 76-76
Open Access | Times Cited: 7
Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs
Farhad Sheikhnia, Ahmad Fazilat, Vahid Rashidi, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155374-155374
Closed Access | Times Cited: 7
Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk
Anna Plym, Yiwen Zhang, Konrad H. Stopsack, et al.
JAMA Network Open (2024) Vol. 7, Iss. 7, pp. e2420034-e2420034
Open Access | Times Cited: 7
Prostate Cancer Early Detection in the European Union and UK
R. Leenen, Lionne D. F. Venderbos, Jozien Helleman, et al.
European Urology (2024)
Open Access | Times Cited: 7
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer
Honghu Zhang, Lin Qi, Yi Cai, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 6
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics
Trishna Desai, Åsa K. Hedman, Marios Dimitriou, et al.
EBioMedicine (2024) Vol. 105, pp. 105168-105168
Open Access | Times Cited: 6
Prostate cancer screening
Rodrigo España-Navarro, Daniel A. González‐Padilla, José Daniel Subiela, et al.
Asian journal of urology (2024)
Open Access | Times Cited: 6
Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update
Elizabeth Schafer, Mathieu Laversanne, Hyuna Sung, et al.
European Urology (2024)
Open Access | Times Cited: 6
Understanding the global cancer statistics 2022: growing cancer burden
Yuxi Liu, Zhibo Zheng
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2274-2276
Closed Access | Times Cited: 5
Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer
Min Zhu, Rasoul Sali, F. Baba, et al.
American Journal of Clinical and Experimental Urology (2024) Vol. 12, Iss. 4, pp. 200-215
Closed Access | Times Cited: 5
RARPKB: a knowledge-guide decision support platform for personalized robot-assisted surgery in prostate cancer
Jiakun Li, Tong Tang, Erman Wu, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 5
Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy – obstacles and perspectives
Jiřina Procházková, Zuzana Kahounová, Jan Vondráček, et al.
Transcription (2024), pp. 1-20
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top